iBCI Optimization for Veterans With Paralysis
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Jul 20, 2022
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "iBCI Optimization for Veterans With Paralysis," is focused on improving the lives of Veterans and others who have difficulty moving or speaking due to conditions like spinal cord injury, ALS (also known as Lou Gehrig’s disease), or strokes. The researchers are working on a special device called a brain-computer interface (BCI), which allows people to control computers and mobile devices just by thinking. This new BCI aims to be more accurate and easier to use, helping individuals gain more independence in their daily lives.
To participate in the study, individuals must be tetraplegic (meaning they have limited or no use of their arms and legs) or unable to speak, and they need to meet specific criteria related to their medical condition. The trial is not yet recruiting participants, but once it starts, those who qualify can expect to test the mobile BCI device in their own homes. This could be a valuable opportunity for individuals seeking new ways to communicate and interact with technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Inclusion criteria are extensive and are determined by the associated BrainGate IDE(clinicaltrials.gov # NCT00912041)
- • Informally, participants will be tetraplegic or anarthric with little or no functional use of the arms and legs
- Exclusion Criteria:
- • Exclusion criteria are extensive and are determined by the associated BrainGate IDE(clinicaltrials.gov # NCT00912041).
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Providence, Rhode Island, United States
Providence, Rhode Island, United States
Patients applied
Trial Officials
John D Simeral, PhD
Principal Investigator
Providence VA Medical Center, Providence, RI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials